Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 6Unknown 2Recruiting 1Available 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Liver Diseases 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 195camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108anlotinib 105S 1 (combination) 105Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × OTHER × fluorocholine × Clear all
NCT01956409 2016-02-04

Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer Diagnosis

National Taiwan University Hospital

Phase 4 Unknown
80 enrolled
Breast

Breast Neoplasms

NCT02074202 2014-02-28

To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma

National Taiwan University Hospital

Phase 3 Unknown
150 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡